XETRA · DMP.DE
Dermapharm Holding SE
€38.55+€0.35 (+0.92%)
Dermapharm Holding SE’s quoted price sits in the lower half of its reported 52-week range, 25.72% below the high.
Loading market information…
XETRA · CEK.DE · EUR
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 04:35 PM UTC. Cached market data; not a live quote.
One-year closing-price history · EUR. Historical prices are not a forecast.
CeoTronics AG’s quoted price sits in the lower half of its reported 52-week range, 44.41% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
CeoTronics AG’s forward annual dividend is €0.20 per share, paid annual. The forward yield is 2.23% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
CeoTronics AG’s next earnings report is currently expected on Jan 22, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow CeoTronics AG’s reporting calendar.
THE COMPANY BEHIND THE TICKER
CeoTronics AG, a German enterprise established in Rödermark in 1985, specializes in providing advanced communication technology worldwide. The company's offerings span mobile digital radio network systems, dedicated end devices for local applications, and a comprehensive suite of professional communication headsets and intercom systems. Its product portfolio features ATEX-certified solutions and radio interfacing adapters. A variety of intercom systems are available, including diverse CT-DECT series models such as case, conference, latency-free, EODCom, and GateCom compact, catering to a wide range of operational needs. Remote units further enhance connectivity with products like the CT BluetoothAdapter, CT-HR PTT, and various CT-MultiPTT units (1C, 2C, 3C, MIL). CeoTronics also boasts an extensive array of professional headsets designed for diverse operational requirements. This includes helmet-independent neckband options (CT-ActionNeckband), in-ear communication devices (CT-ClipCom), modular on-ear designs (CT-CombiCom, CT-GroundCom), and specialized systems for high-noise environments (CT-ContactCom). The range extends to innovative solutions like skullcap microphones (CT-SkullMike), professional throat microphones (CT-ThroatMike, with the Comfort variant for protective suits), and advanced wired digital full-duplex communication systems (CT-WireCom Digital). Additional offerings comprise short-range CT-DECT headset systems, custom CT-Earpieces, and the CT-EarGuard mobile measurement system. These robust communication tools find widespread application across critical industrial sectors, including mechanical engineering, the automotive industry, paper manufacturing, and aerospace.
Latest available per-share figures in EUR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:32 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
€38.55+€0.35 (+0.92%)
Dermapharm Holding SE’s quoted price sits in the lower half of its reported 52-week range, 25.72% below the high.
€9.15€0.00 (0.0%)
centrotherm international AG’s quoted price sits in the lower half of its reported 52-week range, 36.9% below the high.
€3.64-€0.10 (-2.67%)
Msg Life Ag’s quoted price sits in the lower half of its reported 52-week range, 9.0% below the high.
€15.50-€1.00 (-6.06%)
ParTec AG’s quoted price sits in the lower half of its reported 52-week range, 83.94% below the high.
PLN 22.75-PLN 0.25 (-1.09%)
Bloober Team S.A.’s quoted price sits in the lower half of its reported 52-week range, 20.18% below the high.
€25.60+€0.20 (+0.79%)
DATA MODUL Aktiengesellschaft’s quoted price sits in the lower half of its reported 52-week range, 16.88% below the high.
€3.74+€0.01 (+0.27%)
NFON AG’s quoted price sits in the lower half of its reported 52-week range, 33.21% below the high.
€1.69+€0.02 (+1.2%)
Exasol AG’s quoted price sits in the lower half of its reported 52-week range, 45.48% below the high.
